ESPE Abstracts (2024) 98 P3-125

ESPE2024 Poster Category 3 GH and IGFs (21 abstracts)

Impact of Sex Steroid Priming on Growth Hormone Stimulation in Children with Short Stature: A Comparative Study"

Fawzia Alyafei , Noor Hamed , Nada Alaaraj , Nagwa Elsayed , Mohamed Qusad & Ashraf Soliman


Hamad General Hospital, Doha, Qatar


Introduction: Growth hormone (GH) deficiency in children with short stature poses significant diagnostic and therapeutic challenges. Sex steroid priming before GH stimulation tests (GHST) is a strategy employed to enhance the diagnostic accuracy for GH deficiency. However, the efficacy and impact of this approach remain subjects of debate.

Aim: This study aim ed to evaluate the effects of sex steroid priming on various growth and hormonal parameters in short stature children undergoing GH stimulation tests.

Methods: The study involved 40 children with short stature, randomized into two groups: 'With Priming' (n = 20) and 'Without Priming' (n = 20). Parameters assessed included age, height standard deviation score (HTSD), weight standard deviation score (WTSD), BMI standard deviation score (BMISD), growth velocity (GV), GVSD/HVSD, mid-parental height standard deviation (MPHSD), Tanner stage, peak GH level (GHST peak), insulin-like growth factor 1 (IGF1)

Results: Comparison between the two groups "With Priming" and "Without Priming"

Parameter With Priming Group Without Priming Group P-value
Age (years) 11.30 (SD: 3.07) 10.21 (SD: 2.61) 0.2340
HTSD 1 (SD Score) -2.46 (SD: 1.26) -1.95 (SD: 1.20) 0.1978
WTSD 1 (SD Score) -0.12 (SD: 1.49) -1.91 (SD: 0.26) <0.0001
BMISD 1 (SD Score) -1.07 (SD: 1.24) 0.42 (SD: 1.25) 0.0005
GV 1 (cm/year) 3.93 (SD: 2.06) 5.09 (SD: 3.03) 0.1661
MPHSD -1.10 (SD: 1.34) -1.73 (SD: 4.93) 0.5869
Tanner Stage 1.56 (SD: 0.68) 1.25 (SD: 0.43) 0.0945
GHST Peak 6.53 (SD: 5.57) 5.18 (SD: 2.21) 0.3234
IGF1SD -0.31 (SD: 1.01) 0.32 (SD: 1.36) 0.1052

There is no significant difference in the average age, GV or HTSD 1 between the two groups. Mid-Parental Height Standard Deviation (MPHSD) did not differ significantly between the 2 groups (P = 0.5869). Tanner Stage was not different between the two groups (P = 0.0945). No significant difference in GH peak levels is observed (P = 0.3234). However, 4/20 and 8/20 were diagnosed with GHD (peak < 7 ng/dl) in the non-primed vs primed groups. IGF1SD did not differ between the two groups (P = 0.1052).

Conclusion: Sex steroid priming before GH stimulation tests in children with short stature appears to positively influence GH, however, the variability in response between primed and non-primed groups underscores the necessity for individualized diagnostic approaches.

Volume 98

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.